Related Experiment Videos

Comparison of hyperglycemia, hypertension, and hypercholesterolemia management in patients with type 2 diabetes

Richard W Grant1, Enrico Cagliero, Patricia Murphy-Sheehy

  • 1General Medicine Division, Department of Medicine, Harvard Medical School and Massachusetts General Hospital, Boston, Massachusetts 02114, USA.

The American Journal of Medicine
|May 30, 2002
PubMed

Insights

Management of hyperglycemia in type 2 diabetes patients was more aggressive than for hypertension and hypercholesterolemia. Increased screening and more aggressive drug therapy for cardiovascular disease risk factors are needed.

Area of Science:

  • Endocrinology
  • Cardiology
  • Public Health

Background:

  • Cardiovascular disease (CVD) is the primary cause of mortality in type 2 diabetes (T2D) patients.
  • Effective management of hyperglycemia, hypertension, and hypercholesterolemia is crucial for mitigating CVD risk in T2D.
  • This study evaluates the comparative management of these critical risk factors.

Purpose of the Study:

  • To compare the management of hyperglycemia versus cardiovascular disease risk factors (hypertension and hypercholesterolemia) in T2D patients.
  • To assess the intensity of treatment for elevated hemoglobin A1c (HbA1c), blood pressure, and low-density lipoprotein (LDL) cholesterol levels.

Main Methods:

  • A cohort of 601 T2D patients from an academic medical center was analyzed over 18 months.
  • Care assessment included measurement of HbA1c, blood pressure, and total cholesterol levels.
  • Prescription patterns for drug therapy and dose adjustments were compared based on treatment goal achievement.

Main Results:

  • Blood pressure (99%) and HbA1c (92%) levels were more frequently measured than cholesterol levels (76%).
  • Patients with above-goal HbA1c received more drug therapy (92%) and higher doses (80%) compared to those with above-goal blood pressure (78%, 62%) or LDL cholesterol (38%, 13%).
  • Hyperglycemia management demonstrated greater intensity than that for hypertension and hypercholesterolemia.

Conclusions:

  • Hypercholesterolemia and hypertension are managed less aggressively than hyperglycemia in T2D patients.
  • Enhanced screening for hypercholesterolemia and more assertive pharmacotherapy for both hypercholesterolemia and hypertension are warranted.
  • Improved management of these risk factors is essential to reduce cardiovascular disease burden in T2D.
Abstract

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...